Press Releases

Featured Press Releases

Biotechnology Innovation Organization (BIO)…

WASHINGTON, DC (January 7th, 2026) – Today, the Biotechnology Innovation Organization (BIO) announced the launch of the BIO Investment Council (BIC). The newly established council aims to serve small and emerging biotech innovators by increasing…

Learn more

BIO Statement on Changes Announced to the U.S…

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on changes announced to the US childhood vaccine schedule.“American health is as unique as America itself…

Learn more

BIO Statement on December 2025 ACIP Meeting

WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory…

Learn more

Biotechnology’s Leading Trade Group Restructures for the Future

January 19, 2021

Washington, DC – The Biotechnology Innovation Organization (BIO), which announced its transition to a new CEO in June to Dr. Michelle McMurry-Heath, is announcing a new leadership team and organizational structure that promises to provide long…

BIO Applauds Incoming Administration's Decision Elevating Key White House Science Post to Cabinet-level Agency

January 16, 2021

President-elect Joe Biden announced on Friday a plan to make the White House Office of Science and Technology Policy a Cabinet-level agency. Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), made the…

Trump Administration Move to Issue RFS Waivers "Beyond Egregious"

January 12, 2021

Stephanie Batchelor, vice president of BIO's Industrial and Environmental Section, released the following statement in reaction to the Trump administration's move to issue Renewable Fuel Standard (RFS) waivers for the 2019 compliance year. “This…

BIO Releases Statement Concerning Future Political Giving

January 11, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on BIO's political contributions: "As of today BIO will be pausing our political giving so we can…

BIO Statement on CMS' Approval of TennCare Medicaid Waiver

January 11, 2021

Dan Durham, Executive Vice President for Health Policy at the Biotechnology Innovation Organization, released the following statement regarding the recent decision by the Centers for Medicare and Medicaid Services (CMS) to approve the Tennessee…

BIO's Dr. Michelle McMurry-Heath Responds to "Unconscionable" Attacks on U.S. Capitol

January 6, 2021

Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization, made the following comments in response to today's violence at the United States Capitol: "Today we watched in horror as angry and unruly mobs attacked…

Injunction Placed on Punitive and Political Maneuver by Administration

December 29, 2020

A judge in the United States District Court for the Northern District of California yesterday issued a preliminary injunction blocking the Administration’s “Most Favored Nation” reimbursement policy for certain drugs administered by Medicare Part B…

Modernizing Oversight of Animal Biotechnology Will Help Tackle Climate Change and Nutrition Challenges

December 21, 2020

The Biotechnology Innovation Organization (BIO) appreciates the U.S. Department of Agriculture’s (USDA) longstanding commitment to food and agricultural innovation and looks forward to reviewing the Advanced Notice of Proposed Rulemaking (ANPR)…

New Website Will Combat Vaccine Myths, Boost Public Confidence, Increase Acceptance

December 4, 2020

Public opinion polls show there is significant mistrust among the American public in the safety and efficacy of vaccines. So today, the Biotechnology Innovation Organization (BIO) announced the launch of COVIDVaccineFacts.org. As a subsidiary…

BIO Leads Group Challenging Administration’s “Most Favored Nation” Rule

December 4, 2020

The Biotechnology Innovation Organization (BIO), the California Life Sciences Association (CLSA), and BIOCOM California today filed a challenge against the Department of Health and Human Services’ (HHS) attempt, during the final days of the Trump…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.